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Efty Stavrou1*, Nicole Pesa1,2 and Sallie-Anne Pearson1,2Abstract
Background: Population-level health administrative datasets such as hospital discharge data are used increasingly
to evaluate health services and outcomes of care. However information about the accuracy of Australian discharge
data in identifying cancer, associated procedures and comorbidity is limited. The Admitted Patients Data Collection
(APDC) is a census of inpatient hospital discharges in the state of New South Wales (NSW). Our aim was to assess
the accuracy of the APDC in identifying upper gastro-intestinal (upper GI) cancer cases, procedures for associated
curative resection and comorbidities at the time of admission compared to data abstracted from medical records
(the ‘gold standard’).
Methods: We reviewed the medical records of 240 patients with an incident upper GI cancer diagnosis derived
from a clinical database in one NSW area health service from July 2006 to June 2007. Extracted case record data
was matched to APDC discharge data to determine sensitivity, positive predictive value (PPV) and agreement
between the two data sources (κ-coefficient).
Results: The accuracy of the APDC diagnostic codes in identifying site-specific incident cancer ranged from 80-95%
sensitivity. This was comparable to the accuracy of APDC procedure codes in identifying curative resection for
upper GI cancer. PPV ranged from 42-80% for cancer diagnosis and 56-93% for curative surgery. Agreement
between the data sources was >0.72 for most cancer diagnoses and curative resections. However, APDC discharge
data was less accurate in reporting common comorbidities - for each condition, sensitivity ranged from 9-70%,
whilst agreement ranged from κ= 0.64 for diabetes down to κ< 0.01 for gastro-oesophageal reflux disorder.
Conclusions: Identifying incident cases of upper GI cancer and curative resection from hospital administrative data
is satisfactory but under-ascertained. Linkage of multiple population-health datasets is advisable to maximise case
ascertainment and minimise false-positives. Consideration must be given when utilising hospital discharge data
alone for generating comorbidity indices, as disease burden at the time of admission is under-reported.
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The assessment of health services utilisation and asso-
ciated patient outcomes are fundamental to improving
health care performance. However, traditional investiga-
tion methods such as clinical cohort investigations are
resource-intensive and costly. Increasingly, population-
level health administrative data, such as hospital* Correspondence: efty.stavrou@unsw.edu.au
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reproduction in any medium, provided the ordischarge and registry data, used alone or linked with
other datasets, are being used as a cost-effective and
resource-efficient alternative to investigate population
treatment patterns, health service utilisation and out-
comes of care [1,2] across a range of conditions [1,3-9].
Analyses using health administrative data is generally
based on the assumption that the data sets have high
levels of accuracy in identifying medical conditions and
associated treatments and services. In particular there is
widespread use of hospital discharge data in this context,
yet there are relatively few published studies reportingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cedure codes. Some of the well documented limitations
are missing data, abstraction errors and misclassification
errors [10]. Therefore investigations using these data
requires high level expertise from the perspective of the
analysts and in the interpretation of findings [11,12].
In Australia, there have been series of validation stud-
ies investigating the accuracy of hospital discharge data
in identifying obstetric conditions and outcomes [13-16]
but there are fewer studies examining the accuracy of
cancer related diagnoses [17-19] and treatment in dis-
charge data [7,20]. Clearly the identification of accurate
population level cancer-related measures from hospital
discharge data is essential to improved understanding of
treatment processes and outcomes of care. This is par-
ticularly important in circumstances where discharge
data is used as the only information source and not
linked to other population datasets such as cancer
notifications.
Upper gastro-intestinal (upper GI) cancers account for
7% of all incident cancers and 15% of all cancer deaths
in Australia [21]. Surgical resection for curable upper GI
cancers is the standard treatment, with or without adju-
vant chemotherapy. We previously reported on patient
outcomes following curable surgical resection for
oesophageal cancer in New South Wales (NSW), the lar-
gest jurisdiction in Australia, using linked administrative
health data [5]. We expand on this work by examining
the accuracy of hospital administrative discharge diag-
nostic codes in identifying site-specific upper GI cancer
cases and procedure codes for those undergoing curative
resection for site-specific cancer. We also examine the
accuracy of specific comorbidities as recorded in hos-
pital discharge data compared with those listed in pa-
tient medical records.Methods
Setting
Australia has a publicly-funded universal health care sys-
tem. All Australian citizens and permanent residents are
entitled to subsidised treatment from medical practi-
tioners and fully subsidised (free) treatment in public
hospitals [22]. NSW is the largest jurisdiction in Austra-
lia, and until 2011 comprised eight area health services.Study population
Our study population was potential patients with data
indicative of a primary incident upper GI cancer (Inter-
national Classification of Diseases v10 [ICD-10] codes
C15, C16, C22 and C25) in the period July 2006 to June
2007 in an area health service (AHS) clinical database.
Cases were confirmed using data extracted from their
medical records.The South Eastern Sydney Illawarra Area Health Ser-
vice commenced capture of the diagnostic and treatment
details of all patients diagnosed with cancer after 1st
January 2006 or receiving part or all of their treatment
within a health service facility. However, the AHS clin-
ical database does not distinguish between primary and
secondary cancer diagnoses. Nevertheless, this was the
most systematic and cost-effective approach available to
us for identifying potential upper GI incident cancer
cases from which data could be extracted from patient
medical records. Data extracted from the medical
records of confirmed cases was considered to be ‘the
gold standard’.
Hospital discharge database
The Admitted Patient Data Collection (APDC) is a cen-
sus of all inpatient separations (discharges) from all
public, private and repatriation hospitals, private day
procedures centres and public nursing homes in NSW.
Hospital medical coders abstract data from patient
medical records following discharge and submit details
to the NSW Health Information Exchange for every
episode of care. A separate record is processed for each
period of inpatient care, irrespective of the time interval
between the date of separation and subsequent
readmission.
Data linkage
The data linkage process is shown in Figure 1. The AHS
data manager extracted the relevant potential cases with
patient identifiers (eg: name, medical record number,
date-of-birth) and forwarded the extract to the Centre
for Health Record Linkage (CHeReL). The CHeReL
matched AHS cases to APDC records using probabilistic
linkage and best privacy preserving protocols [23]. Each
case and APDC record was assigned a unique identifier
(or Project Person Number: PPN) so as to match indivi-
duals across the two data sets. The research team
received two individual data files: patients with a diagno-
sis or treatment of upper GI cancer within an AHS facil-
ity as recorded in the APDC with PPNs but not patient
identifiers were forwarded to the team analyst; and the
AHS cases with PPNs and identifying information was
sent to the data abstractor who used the information to
identify medical records for review. Data were extracted
from hospital records and sent to the research team ana-
lyst with PPNs and no other personal identifying data in-
formation. Using the PPN, the analyst merged the
abstracted hospital record data with the APDC.
Case record extraction
A data extraction form was developed and pilot tested
by the research team in consultation with a medical
registrar and gastroenterologist. The final version of the
AHS clinical database custodian 
identifies potential UGI cancer cases 
and sends identifying information to 
Data Linka ge Unit (n=472)
Data Linkage Unit links potential UGI 
cases with hospital discharge data 
(APDC). Sends unique project person 
numbers (PPNs) and encrypted record 
number back to AHS and APDC 
AHS clinical database custodian sends 
data extractor f ile with identifying 
information and PPN 
APDC custodian sends PPN and 
diagnosis and procedure codes of UGI 
patients treated in AHS facility to 
researchers
Data extractor requests medical records; 
extracts data; sends analyst data file with 
PPN and abstracted information but no 
identifying information (n=337)
Analyst matches abstracted data with 
APDC using PPN (n=333)
Incident primary cases identified as 
those with ICD -10 code of C15, C16, C22 
or C25 (n=240)
Non -primary upper GI cancers (eg lung 
cancer , cancer unknown primary)
(n=93)
Figure 1 Linkage process.
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teristics, cancer-specific diagnostic and treatment char-
acteristics and the presence of common comorbidities
(eg hypertension, diabetes, ischaemic heart disease) as
suggested for inclusion by the consultants. Most of the
items had response options whereby the trained ex-
tractor was required to indicate the presence of specific
characteristics. To assess inter-rater reliability, a second
trained researcher extracted data from a random selec-
tion of at least 10% of medical records (n= 38; 12%) inde-
pendently. Both extractors were health care professionals
trained in data abstraction by the medical registrar, and
were blind to the diagnostic and treatment details of
patients as described in the APDC.
Statistical analyses
We calculated sensitivity and positive predictive value
(PPV) of the APDC data against the case record data
(gold standard) for the following: 1) diagnosis for site-
specific upper GI cancer; 2) curative resection for site-
specific cancer and 3) comorbid conditions. Sensitivity
was calculated as the proportion of cases/procedures of
cancer or comorbidity reported in the APDC as com-
pared with the true diagnosis/procedure as determined
by the case data. We did not calculate specificity ornegative predictive value as the denominator (the popu-
lation without a GI cancer diagnosis) was not
ascertained.
Of the persons with site-specific cancer diagnosis/pro-
cedure or comorbid condition in the entire APDC (ie
true and false report), the PPV was calculated as the
proportion with a matching case/procedure from
abstracted data (ie true report).
We determined the agreement between the case med-
ical record data and the APDC using the kappa statistic,
which adjusts for the agreement that would be observed
on the basis of chance. A κ-value >0.75 is an indication
of excellent agreement whilst that between 0.40 and 0.75
represents fair to good agreement [24].
We identified surgical resections in the APDC using
the Medicare Benefits Schedule-Extended classification
of the International Classification of Diseases
(ICD_10_AM) procedural block codes for oesophagect-
omy (0858–0860), gastrectomy (875–879), pancreatec-
tomy and excision of lesions of pancreas (978 and 979
90294–01, 30578–00) and excision procedures of the
liver (953) [25]. Upper GI cancer classification recorded
in the APDC as a reason for the episode of care, or
comorbidities were identified using ICD_10_AM diag-
nostic codes from the primary and up to 10 secondary
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were as follows: hypertension (I10-I15), diabetes (E10.1,
E10.5, E10.9, E11.1, E11.5, E11.9, E13.1, E13.5, E13.9,
E14.1, E14.5, E14.9), ischemic heart disease (I2-I25),
GORD (K21.0, K21.9), alcohol abuse (F10.1, F10.2, K70,
Z72.1, Z86.41), hepatitis B or C (B16, B18, B19, K73),
chronic obstructive pulmonary disease (J44) and demen-
tia (F01-F03).
We also used the kappa statistic to calculate inter-
rater reliability of the extracted data for cancer diagno-
sis, curative resection and comorbidity. Inter-rater reli-
ability between the record extractors was κ= 0.91 and
κ= 0.74 for overall site-specific cancer diagnosis and
curative surgery respectively. Agreement for specific
comorbidities was κ =1.00 for diabetes, ischaemic heart
disease and hypertension and κ =0.64 for gastro-
oesophageal reflux disease (GORD). Hence we felt the
data obtained by the main extractor could be analysed
with confidence.
All statistical analyses were performed using SAS soft-
ware, version 11.2 (SAS Institute Inc, Cary, NC).
The study was approved by the NSW Population and
Health Services Research Ethics Committee (Ref 2010/
05/253) and site specific approvals from Prince of Wales,
St George, Sutherland and Wollongong Hospitals.
Results
Cohort characteristics
Of the 472 potential cases identified in AHS clinical
database, 337 (71%) were available for review; however
due to mismatching errors during the data linkage
process, four records did not link to the APDC. Of the
remaining 333 medical records 240 patients had an inci-
dent diagnosis of upper GI cancer; this constituted our
study cohort. The majority of patients without incident
upper GI cancer (n = 91/333) had another primary can-
cer type (eg lung, renal cell, unknown primary site) and
there was insufficient information in the medical records
or associated notes to determine cancer diagnosis type
for the remaining two patients.
Over half of the 240 patients with upper GI cancer as
classified in the medical chart review were >70 years of
age in 2006 (55%), with 35% aged 51–70 years; compar-
able to patients with no primary diagnosis of upper GI
cancer (63% and 27% respectively). 32% (n = 76) of the
cases had an incident diagnosis of pancreatic cancer,
30% (n = 71) gastric cancer, 25% (n = 59) oesophageal
cancer and 14% (n = 34) liver cancer. Only 27% (64/240)
of all upper GI cancer patients had curative surgery; the
majority being for gastric cancer (42%) and pancreatic
cancer (27%). The most common comorbidity reported
in the study cohort was hypertension (50% of patients),
with fewer reports of diabetes (32%), GORD (20%), is-
chaemic heart disease (IHD: 18%), alcohol abuse (9%) orHepatitis B or C (7%). Similar comorbidity profiles were
found in the patients not classified with upper GI cancer
from the medical chart review.
Cancer diagnosis and surgical resection
Compared with the medical records, overall sensitivity
for site-specific cancer diagnosis for the APDC was 89%
(95% CI 84-93%). Sensitivity for each cancer diagnosis
was satisfactory, ranging from 80% (95% CI 67-89%) for
oesophageal cancer to 95% (95%CI 86-98%) for pancre-
atic cancer (Table 1). Overall sensitivity for curative sur-
gery for upper GI cancer from the APDC was 84% (95%
CI 73-92%), ranging from 67% (95% CI 24-94%) for
oesophageal cancer to 91% (95%CI 57-99%) for liver
cancer.
Misclassification was the most common reason for
false-negative reports in the hospital discharge data; for
diagnosis 11 oesophageal cancers were classified as gastric
cancer, whilst seven gastric, two liver and four pancreatic
cancers were misclassified as another primary cancer
(such as lung cancer or renal cell carcinoma). Two surger-
ies for oesophageal cancer were misclassified in the dis-
charge data as occurring for gastric cancer, three
pancreatic and three gastric cancer surgeries were misclas-
sified as occurring for liver cancer and one liver cancer
was assigned to another primary cancer (renal cell).
PPV for diagnosis of incident cancer in the APDC ran-
ged from 42% for liver cancer to 81% for pancreatic can-
cer. With the exception of liver cancer, PPV for curative
surgery was reasonably high (ranging from 79% to 93%).
Hence, although incident cases and procedures were
under-ascertained, fair to very good agreement between
the two data sources was shown for cancer diagnosis (κ-
coefficient ranging from 0.42 to 0.84) and curative sur-
gery (κ-coefficient ranging from 0.68 to 0.83) (Table 1).
Comorbidity
Sensitivity was highest for dementia (70.0%, 95%CI 35-
92%) and lowest for GORD (8.5%, 95%CI 3-21%). PPV
was variable, ranging from 17% (95%CI 6-38%) for
GORD to 98% (95%CI 87-100%) for diabetes. Agreement
between the two data sources was low to fair. Comor-
bidities were underreported in the APDC.
Discussion
There is widespread and increasing use of population-
level hospital discharge diagnostic and procedural codes
to monitor processes and outcome of care for health ser-
vices research. The validation of coding in health admin-
istrative datasets has been identified as a priority in
health services research by an international consortium
[26]. However, validation studies remain uncommon
[11]. This study contributes to the body of knowledge
regarding the accuracy of administrative hospital













UGI cancer diagnosis 240 214 89.2 (84.4-92.7)
Oesophagus 59 47 79.7 (66.8-88.6) 18 72.3 (60.4-81.7) 0.72 (0.63-0.81)
Gastric 71 63 88.7 (78.5-94.7) 22 74.1 (63.9-82.2) 0.75 (0.62-0.89)
Liver 34 32 94.1 (79.0-99.0) 45 41.6 (31.8-52.3) 0.42 (0.30-0.52)
Pancreas 76 72 94.7 (86.4-98.3) 17 80.9 (71.5-87.7) 0.84 (0.78-0.90)
Curative surgery 64 54 84.4 (72.7-91.9)
Oesophagus 6 4 66.7 (24.1-94.0) 1 80.0 (30.0-98.9) 0.79 (0.52-0.98)
Gastric 30 27 90.0 (72.3-97.4) 7 79.4 (63.2-89.6) 0.83 (0.74-0.94)
Liver 11 10 90.9 (57.1-99.5) 8 55.6 (33.7-75.4) 0.68 (0.48-0.87)
Pancreas 17 13 76.5 (49.8-91.2) 1 92.9 (68.5-98.7) 0.83 (0.69-0.98)
Comorbid conditions
Hypertension 120 74 61.7 (52.3-70.3) 50 59.7 (50.9-67.9) 0.37 (0.28-0.47)
Diabetes 78 45 57.7 (46.0-68.6) 1 97.8 (87.0-99.9) 0.64 (0.53-0.74)
IHD* 42 20 47.6 (32.3-63.4) 17 54.0 (37.1-70.2) 0.41 (0.26-0.56)
GORD* 47 4 8.5 (2.8-21.3) 20 16.7 (5.5-38.2) <0.01 (−−, 0.09)
Alcohol abuse 21 12 57.1 (34.4-77.4) 16 42.9 (26.5-60.9) 0.40 (0.22-0.60)
Hepatitis B or C 17 6 35.3 (15.3-61.4) 3 66.7 (35.4-87.9) 0.47 (0.22-0.73)
COPD* 7 3 42.9 (11.8-79.8) 8 27.3 (7.3-60.7) 0.33 (0.04-0.68)
Dementia 10 7 70.0 (35.4-91.9) 4 63.6 (35.4-84.8) 0.72 (0.51-0.96)
* IHD= Ischaemic heart disease;42 GORD=gastro-oesophageal reflux disease; COPD= chronic obstructive pulmonary disease.
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associated resection and comorbidity. This study also
adds to the current literature on the nature and extent
of reporting of comorbid diseases in population adminis-
trative data.
The distribution of site-specific cancers reported in
our study was similar to the distribution of upper GI
cancers in the Australian population [21]. The propor-
tion of patients undergoing curative resection was also
consistent with other studies [5,27,28]. We demonstrated
that the APDC records cancer diagnosis and procedures
at an acceptable level when compared to the medical
record gold standard. We obtained similar levels of sen-
sitivity for diagnosis compared to previous validation
studies examining other cancers [17-19]. Previous valid-
ation studies examining breast and prostate cancer diag-
noses have also shown surgical procedure records in
administrative data to be well reported both in New
South Wales [7,20] and internationally [29,30]. Never-
theless, true incident cancer cases and procedures from
administrative data are still under-reported [31,32] and
hence linkage with other datasets, such as registry-based
data is recommended for case-ascertainment. Con-
versely, using hospital discharge data as the source for
detecting incident upper GI cancer will over-estimate
the incident rate, as false-positives are reported.Our study also demonstrated the lower validity of
common comorbidities reported in hospital discharge
data. Despite an improvement in the accuracy of comor-
bid coding (with the introduction of ICD-10 coding) in
administrative data over recent years, sensitivity when
compared with medical records is generally low [33].
Our finding is consistent with a previous Australian
study reporting under-ascertainment in more than 80 of
100 conditions in hospital discharge data [34]. The
under-ascertainment of comorbidities in administrative
data has been attributed to incompleteness of data trans-
fer from medical records in individual hospitals to ad-
ministrative databases [34-36]. Hospital coders are
required to report medical conditions that affect the spe-
cific admission, however financial incentives may also im-
pact on comorbidities which are reported. For example,
recording of certain comorbidities over others may occur
due to their effect on patient length-of-hospital-stay and
procedures performed resulting in greater financial re-
imbursement to the hospital. Misclassification of similarly
related diseases (eg Barrett’s oesophagus versus GORD,
COPD versus emphysema) may also occur. Clearly, the
under-reporting of common comorbidities has implica-
tions for researchers using hospital discharge data as
the sole source for assessing incidence, procedures, health
outcomes and patient comorbidity as our study and others
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incomplete.
Population dataset linkage is a cost-effective and at-
tractive method for undertaking health services research,
as large representative cohorts can be investigated effi-
ciently when compared with traditional methods of
recruiting participants from the population of interest.
However, the validation of codes used to identify
patients with particular health states and/or undergoing
hospital procedures is essential to avoid misclassification
bias which has the potential to undermine the internal
validity and interpretation of study findings. This valid-
ation study showed that hospital discharge data has
some limitation in the reporting of cancer, related cura-
tive resection and comorbidity. The outcomes from this
validation study on cancer-related hospital administra-
tive data will be important for consideration of future
cancer surgical prevalence and outcomes by researchers
and policy makers.
However, this validation study was limited to one
clinical cancer group in an urban AHS in NSW, of
which only 70% of the cases could be reviewed. Never-
theless, as cases were from four different hospital sites
and the capture of cases is extremely high, it was
thought that selection bias would be minimal and that
the medical record data were indicative of records in
the AHS clinical database. However, future studies
should assess data accuracy across multiple jurisdictions
and across several cancers. In addition, we used an
AHS clinical database to assist in identifying potential
GI cancer cases, as doing otherwise would have been
significantly more time and cost intensive. This method
does not allow for estimates of the NSW population
without upper GI cancer, hence specificity and negative
predictive value of the hospital discharge data could not
be measured.Conclusions
Hospital administrative data provide a valid method of
investigating health outcomes. However cases, proce-
dures and comorbidity in population-level hospital dis-
charge data is under-ascertained and hence researchers
and policy-makers should acknowledge this in research
and health planning assessments. Linkage across multiple
datasets is recommended to improve case ascertainment.Competing interests
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